Holen Sie sich die Stockscreener-App
2.96
6.92%
-0.22
Handel nachbörslich:
2.98
0.02
+0.68%
Schlusskurs vom Vortag:
$3.18
Offen:
$3.18
24-Stunden-Volumen:
94,707
Relative Volume:
0.30
Marktkapitalisierung:
$22.07M
Einnahmen:
$34.75M
Nettoeinkommen (Verlust:
$-24.76M
KGV:
-0.2467
EPS:
-12
Netto-Cashflow:
$-50.91M
1W Leistung:
+3.50%
1M Leistung:
+21.31%
6M Leistung:
-5.13%
1J Leistung:
-88.16%
1-Tages-Spanne:
$2.92
$3.18
1-Wochen-Bereich:
$2.7736
$3.18
52-Wochen-Spanne:
$2.15
$25.00
Allurion Technologies Inc Stock (ALUR) Company Profile
Firmenname
Allurion Technologies Inc
Sektor
Branche
Telefon
508-647-4000
Adresse
11 HURON DR STE 200, NATICK
Vergleichen Sie ALUR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
2.96 | 19.32M | 34.75M | -24.76M | -50.91M | -12.00 |
|
ABT
Abbott Laboratories
|
131.74 | 232.02B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.19 | 151.51B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
390.87 | 148.85B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.78 | 113.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.14 | 44.81B | 5.54B | 4.18B | 623.10M | 7.00 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | Eingeleitet | TD Cowen | Buy |
| 2024-09-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-02-09 | Eingeleitet | Jefferies | Buy |
Allurion Technologies Inc Aktie (ALUR) Neueste Nachrichten
Why Allurion Technologies Inc. stock attracts strong analyst attentionTop Gaining Low Risk Assets - Newser
What makes Allurion Technologies Inc. stock price move sharplyVerified Chart Patterns - Newser
How Allurion Technologies Inc. stock performs during market volatilitySmart Money Signals - Newser
Why Allurion Technologies Inc. Equity Warrant stock attracts strong analyst attentionHigh Potential Shares - Newser
How Allurion Technologies Inc. Equity Warrant stock performs during market volatilityHigh Potential Stock Ideas - Newser
What makes Allurion Technologies Inc. Equity Warrant stock price move sharplyMinimized Risk Maximum Return - Newser
Allurion Technologies stock rises on Canadian distribution partnership By Investing.com - Investing.com South Africa
Allurion Technologies stock rises on Canadian distribution partnership - Investing.com
Allurion partners with Minogue Medical to expand weight loss program in Canada By Investing.com - Investing.com South Africa
Allurion Forms Distribution Partnership with Minogue Medical in Canada - MarketScreener
Allurion Technologies announces distribution partnership with Minogue - TipRanks
Allurion partners with Minogue Medical to expand weight loss program in Canada - Investing.com
Allurion Expands Metabolic Weight Loss Program to Canadian Market | ALUR Stock News - Stock Titan
Allurion submits final PMA module for weight loss balloon to FDA - Investing.com Canada
Allurion submits final PMA module for weight loss balloon to FDA By Investing.com - Investing.com South Africa
Allurion Announces Submission of PMA to FDA and Additional Analyses From Pivotal AUDACITY Study That Meet Both Endpoints - Yahoo Finance
Allurion's Revolutionary Weight Loss Balloon Achieves 4.34% Superior Weight Loss in Pivotal FDA Trial - Stock Titan
Major Weight Loss Breakthrough: 20,000 Patient Study Reveals Muscle-Preserving Success of Allurion Program - Stock Titan
Allurion Announces Findings from New Studies on Muscle Mass Maintenance in Nearly 20,000 Patients and Four-Year Weight Loss Outcomes at the 2025 Annual Meeting of the ASMBS - New Castle News
Allurion Technologies Inc. (NYSE:ALUR) Short Interest Down 42.4% in May - Defense World
(ALUR) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Allurion Technologies (NYSE:ALUR) Trading 2.1% Higher – Time to Buy? - Defense World
Allurion at Jefferies Conference: Strategic US Market Entry By Investing.com - Investing.com South Africa
Allurion at Jefferies Conference: Strategic US Market Entry - Investing.com Australia
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - The Globe and Mail
Allurion to Present at Jefferies Global Healthcare Conference - BioSpace
When the Price of (ALUR) Talks, People Listen - news.stocktradersdaily.com
ALURALLURION TECHNOLOGIES INC Latest Stock News & Market Updates - Stock Titan
Weight Loss Pioneer Allurion Takes Center Stage at Major Jefferies Healthcare Conference - Stock Titan
Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results - MSN
Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program - BioSpace
Allurion Weight Loss Program Builds Muscle Mass 6.6%, Cuts Fat 11% in Clinical Study | ALUR Stock News - Stock Titan
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance
4 Medical Product Stocks to Watch From a Challenging Industry - Yahoo Finance
Allurion Technologies Q1 2025: Unpacking Key Contradictions in Financial Outlook, Revenue Growth, and Regulatory Strategy - AInvest
Trend Tracker for (ALUR) - news.stocktradersdaily.com
Research Analysts Offer Predictions for ALUR FY2025 Earnings - Defense World
Yale University's Strategic Exit from Allurion Technologies Inc: A 13F Filing Insight - GuruFocus
Allurion Technologies Earnings Call: Transition and Growth - TipRanks
Allurion outlines path to FDA submission and expects revenue ramp as B2B2C strategy expands in 2025 - MSN
Allurion Technologies, Inc. (ALUR) Q1 Earnings Beat Estimates - MSN
Allurion Technologies Inc (ALUR) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Allurion Technologies Reports Q1 2025 Financial Results - TipRanks
Finanzdaten der Allurion Technologies Inc-Aktie (ALUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):